Molecular and imaging predictors of response to ado-trastuzumab emtansine in patients with HER2 mutant lung cancers: An exploratory phase 2 trial Meeting Abstract


Authors: Li, B.; Offin, M.; Hembrough, T.; Cecchi, F.; Shen, R.; Olah, Z.; Panora, E.; Myers, M.; Brzostowski, E.; Buonocore, D.; Ginsberg, M.; Rudin, C.; Kris, M.; Weitsman, G.; Barber, P.; Ng, T.; Ulaner, G.; Arcila, M.; Scaltriti, M.
Abstract Title: Molecular and imaging predictors of response to ado-trastuzumab emtansine in patients with HER2 mutant lung cancers: An exploratory phase 2 trial
Meeting Title: IASLC 19th World Conference on Lung Cancer
Keywords: antibody drug conjugate; her2 mutant lung cancers; her2 targeted imaging
Journal Title: Journal of Thoracic Oncology
Volume: 13
Issue: 10 Suppl.
Meeting Dates: 2018 Sep 23-26
Meeting Location: Toronto, Canada
ISSN: 1556-0864
Publisher: Elsevier Inc.  
Date Published: 2018-10-01
Start Page: S599
Language: English
ACCESSION: WOS:000454014502055
DOI: 10.1016/j.jtho.2018.08.900
PROVIDER: wos
Notes: Meeting Abstract: P1.13-43 -- Source: Wos
Altmetric Score
MSK Authors
  1. Gary Ulaner
    81 Ulaner
  2. Michelle S Ginsberg
    154 Ginsberg
  3. Ronglai Shen
    125 Shen
  4. Maria Eugenia Arcila
    325 Arcila
  5. Mark Kris
    569 Kris
  6. Charles Rudin
    152 Rudin
  7. Elizabeth   Panora
    3 Panora
  8. Bob Tingkan Li
    56 Li
  9. Michael David Offin
    13 Offin
  10. Zachary T Olah
    3 Olah
  11. Mackenzie Myers
    2 Myers